DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News
EPG Online Disease Knowledge Centres Feed Disease Knowledge
Recent UK Drug Updates Drug Updates
EPG Search
Frequent Searches:
Search
Languages

Medical News Headlines
Expert praises Parkinson's treatment
The treatment of Parkinson's disease with levodopa has been discussed...
Published Thursday 04 December 2008

Annual report finds cancer initiative a success
A new initiative that aims to improve the treatment of...
Published Thursday 04 December 2008

New game could help tackle obesity and diabetes in kids, expert claims
A new scheme from the British Heart Foundation (BHF) will...
Published Thursday 04 December 2008

Some "good cholesterol" not good enough, study suggests
A number of preconceptions about "good" HDL cholesterol have been...
Published Tuesday 02 December 2008

More Medical News
Browse Other Languages
Parkinson's disease (PD) is a degenerative disorder of the central nervous system characterized by the clinically asymmetric onset of resting tremor, bradykinesia, rigidity and postural instability. Calendar of this months Global and European Medical conferences in Healthcare Low-density lipoprotein cholesterol (LDL-C) has been shown to be strongly associated with the development of atherosclerosis, Cardiovascular Heart Disease (CHD) Types of chronic pain include both cancer and non-cancer pain. Pain is the single most common reason for consultation with a general practitioner and is the most frequent symptom in hospital practice.
More NewsEPG Online News
Disease specific news: VAP, ARDS patients display no added mortality risk
24 Apr 2008

There appears to be no association between mortality and ventilator-associated pneumonia (VAP) among patients with trauma or acute respiratory distress syndrome (ARDS), a study claims.

It is believed that VAP increases mortality in intensive-care unit patients owing to its occurrence in the presence of nosocomial infections; however results of studies investigating this association have hitherto been "contradictory", researchers claim.

The latest study therefore determined the mortality attributable to VAP by systematically identifying and quantitatively combining all of the available observational studies, which included those comparing patients with VAP against control patients, all patients mechanically ventilated and mortality rates.

Out of 2,267 individual citations retrieved, 52 studies with a total of 17,347 patients satisfied the inclusion criteria.

Analysis of the pooled studies showed a significant relative risk (RR) for an association of VAP with increased mortality.

However lead investigator Dr Marianne Melsen noted that a "great amount of heterogeneity was found".

On pooling the data from the nine studies that included only patients with trauma, or the four studies containing only patients with ARDS, researchers found almost no heterogeneity and no association between mortality and VAP.

"Although there is variation among the results, there is probably an attributable mortality of VAP. However, it differs among the patient subgroups," Dr Melsen said.

While there is evidence of significantly increased RR of mortality in specific subgroups of patients with VAP, this is not seen for patients with trauma and ARDS.

Findings were presented at the European Congress of Clinical Microbiology and Infectious Disease and reported by DGDispatch.

Click here for EPG Online physician's tools including disease awareness, diagnosis tools, treatment options and management guidanceADNFCR-1419-ID-18566679-ADNFCR

Print Article    Bookmark Bookmark
Related News Stories (Clinical / Disease-specific News)

FEATURES

DRUG UPDATES Drug updates feed

EMAIL BULLETINS

MEDICAL NEWS EPG News Feed

DISEASE CENTRES Disease Centres feed

RESEARCH

GOOGLE SEARCH

GUIDELINES

DRUG DATA UK Drug Data Feed